Breaking News

Frenova Renal Research Retains SCORR Marketing

May 9, 2014

To develop strategies to support Frenova’s dedication to renal research

Frenova Renal Research has named SCORR Marketing, a marketing communications company focused on drug and device development services, as its agency.
 
Frenova, formerly the Clinical Studies Group of Fresenius Medical Care North America, is a Phase I-IV drug and device clinical development services company dedicated exclusively to renal research. Frenova’s goal is to provide an intimate understanding of patients affected by kidney disease and to improve the quality of life for people with renal impairment.
 
“As the industry’s only dedicated renal CRO, Frenova Renal Research is providing something that other CROs can’t," said Cinda Orr, president and chief executive officer of SCORR Marketing. "We helped Frenova unveil its new name and brand identity at the recent Partnerships in Clinical Trials 2014 and are excited to develop strategies that will effectively support Frenova’s mission of improving the lives of those affected by a renal impairment.”

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016